Welcome to LookChem.com Sign In|Join Free

CAS

  • or

56-17-7

Post Buying Request

56-17-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

56-17-7 Usage

Chemical Properties

white powder

Uses

Different sources of media describe the Uses of 56-17-7 differently. You can refer to the following data:
1. hepatoprotectant, t-glutaminase inhibitor, heat shock protein promoter, caspase inhibitor
2. sulfhydryl modifying reagent and heparin antagonist
3. Cystamine dihydrochloride acts as an anti-infective agent, which is used in the treatment of urinary tract infections. It is also used as a radiation-protective agent that interferes with sulfhydryl enzymes. Further, it serves as a heparin antagonist and sulfhydryl modifying reagent. In addition to this, it is used as an inhibitor of TGase.

Safety Profile

A poison by subcutaneous and intraperitoneal routes. Experimental reproductive effects. When heated to decomposition it emits very toxic fumes of HCl, SOx, and NOx. See also SULFIDES.

Purification Methods

Recrystallise the salt by dissolving in EtOH containing a few drops of dry EtOH/HCl, filtering and adding dry Et2O. The solid is dried in a vacuum and stored in a dry and dark atmosphere. It has been recrystallised from EtOH (solubility: 1g in 60mL of boiling EtOH) or MeOH (plates). The free base has b 90-Purification of Biochemicals — Amino Acids and Peptides 100o/0.001mm, 106-108o/5mm and 135-136o/760mm, d 4 1.1559, n D 1.5720. [Verly & Koch Biochem J 58 663 1954, Gonick et al. J Am Chem Soc 76 4671 1954, Jackson & Block J Biol Chem 113 137 1936.] The dihydrobromide has m 238-239o (from EtOH/Et2O) [Viscontini Helv Chim Acta 36 835 1953]. [Beilstein 4 H 287, 4 IV 1578.]

Check Digit Verification of cas no

The CAS Registry Mumber 56-17-7 includes 5 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 2 digits, 5 and 6 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 56-17:
(4*5)+(3*6)+(2*1)+(1*7)=47
47 % 10 = 7
So 56-17-7 is a valid CAS Registry Number.
InChI:InChI=1/C4H12N2S2/c5-1-3-7-8-4-2-6/h1-6H2/p+2

56-17-7 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (C0875)  Cystamine Dihydrochloride  >97.0%(N)

  • 56-17-7

  • 25g

  • 295.00CNY

  • Detail
  • TCI America

  • (C0875)  Cystamine Dihydrochloride  >97.0%(N)

  • 56-17-7

  • 100g

  • 695.00CNY

  • Detail
  • TCI America

  • (C0875)  Cystamine Dihydrochloride  >97.0%(N)

  • 56-17-7

  • 500g

  • 1,990.00CNY

  • Detail
  • Alfa Aesar

  • (B22873)  Cystamine dihydrochloride, 97+%   

  • 56-17-7

  • 25g

  • 226.0CNY

  • Detail
  • Alfa Aesar

  • (B22873)  Cystamine dihydrochloride, 97+%   

  • 56-17-7

  • 100g

  • 649.0CNY

  • Detail
  • Sigma-Aldrich

  • (02712)  Cystaminedihydrochloride  PharmaGrade, Manufactured under appropriate GMP controls for pharma or biopharmaceutical production.

  • 56-17-7

  • 02712-100G

  • 9,798.75CNY

  • Detail
  • Sigma

  • (C8707)  Cystaminedihydrochloride  BioXtra

  • 56-17-7

  • C8707-25G

  • 2,612.61CNY

  • Detail
  • Sigma

  • (C8707)  Cystaminedihydrochloride  BioXtra

  • 56-17-7

  • C8707-100G

  • 8,037.90CNY

  • Detail
  • Sigma-Aldrich

  • (30050)  Cystaminedihydrochloride  purum, ≥98.0% (AT)

  • 56-17-7

  • 30050-25G-F

  • 258.57CNY

  • Detail
  • Sigma-Aldrich

  • (30050)  Cystaminedihydrochloride  purum, ≥98.0% (AT)

  • 56-17-7

  • 30050-100G-F

  • 875.16CNY

  • Detail
  • Aldrich

  • (C121509)  Cystaminedihydrochloride  96%

  • 56-17-7

  • C121509-25G

  • 458.64CNY

  • Detail
  • Aldrich

  • (C121509)  Cystaminedihydrochloride  96%

  • 56-17-7

  • C121509-100G

  • 1,267.11CNY

  • Detail

56-17-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name Cystamine dihydrochloride

1.2 Other means of identification

Product number -
Other names CYSTAMINIUM DICHLORIDE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:56-17-7 SDS

56-17-7Synthetic route

C23H26N2O3S

C23H26N2O3S

A

cystamine dihydrochioride
56-17-7

cystamine dihydrochioride

B

4-phenyl-1-(phenylmethyl)-2,3-azetidinedione

4-phenyl-1-(phenylmethyl)-2,3-azetidinedione

Conditions
ConditionsYield
Stage #1: C23H26N2O3S With hydrogenchloride In ethyl acetate at 60℃; for 4h;
Stage #2: With oxygen In chloroform at 25℃; for 720h; Further stages.;
A n/a
B 99%
2-mercaptoethylamine hydrochloride
156-57-0

2-mercaptoethylamine hydrochloride

cystamine dihydrochioride
56-17-7

cystamine dihydrochioride

Conditions
ConditionsYield
With dimethyl sulfoxide at 90℃; for 6h;98%
With di(benzothiazol-2-yl)disulfide In methanol; chloroform for 2h; Ambient temperature;96.9%
In methanol oxidation;
With dimethyl sulfoxide In water
In dimethyl sulfoxide at 90℃; for 8h;
di(benzothiazol-2-yl)disulfide
120-78-5

di(benzothiazol-2-yl)disulfide

2-mercaptoethylamine hydrochloride
156-57-0

2-mercaptoethylamine hydrochloride

A

cystamine dihydrochioride
56-17-7

cystamine dihydrochioride

B

2-(Benzothiazol-2-yldisulfanyl)-ethylamine; hydrochloride

2-(Benzothiazol-2-yldisulfanyl)-ethylamine; hydrochloride

Conditions
ConditionsYield
In ethanol; chloroform Ambient temperature;
(3SR,4SR)-3-phenyl-2-(phenylmethyl)-5-thia-2,8-diazaspiro[3.4]octan-1-one hydrochloride

(3SR,4SR)-3-phenyl-2-(phenylmethyl)-5-thia-2,8-diazaspiro[3.4]octan-1-one hydrochloride

A

cystamine dihydrochioride
56-17-7

cystamine dihydrochioride

B

4-phenyl-1-(phenylmethyl)-2,3-azetidinedione

4-phenyl-1-(phenylmethyl)-2,3-azetidinedione

Conditions
ConditionsYield
In chloroform; dimethyl sulfoxide at 45℃; for 6h;A 23 mg
B 52 mg
cystamine dihydrochioride
56-17-7

cystamine dihydrochioride

C23H26N2O7

C23H26N2O7

N,N'-biscystamine
112042-52-1

N,N'-biscystamine

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran; water Ambient temperature;100%
succinic acid anhydride
108-30-5

succinic acid anhydride

cystamine dihydrochioride
56-17-7

cystamine dihydrochioride

N,N'-(3,4-dithia-hexanediyl)-bis-succinamic acid
108725-86-6

N,N'-(3,4-dithia-hexanediyl)-bis-succinamic acid

Conditions
ConditionsYield
With sodium hydroxide In water at 20℃; pH=10;100%
With sodium hydroxide In water pH=10;100%
Stage #1: succinic acid anhydride; cystamine dihydrochioride With sodium hydroxide In water at 20℃; pH=7 - ~ 10;
Stage #2: With hydrogenchloride In water Product distribution / selectivity;
90%
Stage #1: cystamine dihydrochioride With sodium hydroxide In water pH=10;
Stage #2: succinic acid anhydride In water at 20℃; for 2h; pH=7 - 10;
Stage #3: With hydrogenchloride In water
90%
cystamine dihydrochioride
56-17-7

cystamine dihydrochioride

C40H40N2O12S2
1428361-11-8

C40H40N2O12S2

Conditions
ConditionsYield
Stage #1: cystamine dihydrochioride With pyridine In ethanol at 20℃; for 0.5h; Inert atmosphere;
Stage #2: (+)-usnic acid With pyridine In ethanol for 8h; Reflux;
100%
cystamine dihydrochioride
56-17-7

cystamine dihydrochioride

C40H40N2O12S2

C40H40N2O12S2

Conditions
ConditionsYield
Stage #1: cystamine dihydrochioride With pyridine In ethanol at 20℃; for 0.5h;
Stage #2: (+)-usnic acid With pyridine In ethanol for 8h; Inert atmosphere; Reflux;
100%
cystamine dihydrochioride
56-17-7

cystamine dihydrochioride

mitomycin A
4055-39-4

mitomycin A

7-N,7'-N'-bis(2-ethyl)mitomycin C disulfide
93367-29-4

7-N,7'-N'-bis(2-ethyl)mitomycin C disulfide

Conditions
ConditionsYield
With triethylamine In methanol99%
With triethylamine In methanol for 10h; Ambient temperature;99%
With TEA In methanol at 20℃; for 24h;99%
glutaric anhydride,
108-55-4

glutaric anhydride,

cystamine dihydrochioride
56-17-7

cystamine dihydrochioride

N,N'-diglutaroylcystamine
109477-57-8

N,N'-diglutaroylcystamine

Conditions
ConditionsYield
With sodium hydroxide In water at 20℃; pH=10;99%
With sodium hydroxide In water pH=10;99%
Stage #1: glutaric anhydride,; cystamine dihydrochioride With sodium hydroxide In water at 20℃; pH=7 - ~ 10;
Stage #2: With hydrogenchloride In water
90%
Stage #1: cystamine dihydrochioride With sodium hydroxide In water pH=10;
Stage #2: glutaric anhydride, In water at 20℃; for 2h; pH=7 - 10;
Stage #3: With hydrogenchloride In water
90%
pyrazole-1-methanol
1120-82-7

pyrazole-1-methanol

cystamine dihydrochioride
56-17-7

cystamine dihydrochioride

C20H28N10S2

C20H28N10S2

Conditions
ConditionsYield
With triethylamine In dichloromethane at 20℃; for 24h;99%
(3,5-dimethyl-1H-pyrazol-1-yl)methanol
85264-33-1

(3,5-dimethyl-1H-pyrazol-1-yl)methanol

cystamine dihydrochioride
56-17-7

cystamine dihydrochioride

C28H44N10S2

C28H44N10S2

Conditions
ConditionsYield
With triethylamine In dichloromethane at 20℃; for 24h;98%
cystamine dihydrochioride
56-17-7

cystamine dihydrochioride

Methacryloyl chloride
920-46-7

Methacryloyl chloride

N,N'-(disulfanediylbis(ethane-2,1-diyl))bis(2-methylacryl amide)

N,N'-(disulfanediylbis(ethane-2,1-diyl))bis(2-methylacryl amide)

Conditions
ConditionsYield
Stage #1: cystamine dihydrochioride With sodium hydroxide In water at 5℃; for 0.5h;
Stage #2: Methacryloyl chloride In water at 5 - 20℃; for 4h;
98%
Stage #1: cystamine dihydrochioride With sodium hydroxide In water for 0.333333h; Cooling with ice;
Stage #2: Methacryloyl chloride In dichloromethane; water at 0℃; for 3h;
47%
cystamine dihydrochioride
56-17-7

cystamine dihydrochioride

N-methylmitomycin A
18209-14-8

N-methylmitomycin A

7-N,7'-N'-bis(2-ethyl)porfiromycin disulfide

7-N,7'-N'-bis(2-ethyl)porfiromycin disulfide

Conditions
ConditionsYield
With triethylamine In methanol for 10h; Ambient temperature;97%
BOC-glycine
4530-20-5

BOC-glycine

cystamine dihydrochioride
56-17-7

cystamine dihydrochioride

N,N'-bis<(tert-butyloxycarbonyl)glycyl>cystamine
97314-11-9

N,N'-bis<(tert-butyloxycarbonyl)glycyl>cystamine

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In dichloromethane at 0 - 20℃;97%
With benzotriazol-1-ol; N-(3-dimethylaminopropyl)-N-ethylcarbodiimide; triethylamine In dichloromethane at 0℃; for 0.5h;82%
Stage #1: BOC-glycine With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane for 0.333333h;
Stage #2: cystamine dihydrochioride With triethylamine In dichloromethane at 20℃; for 10h; Further stages.;
63%
3-azido-4-fluorobenzoic acid 2,5-dioxopyrrolidin-1-yl ester
934611-70-8

3-azido-4-fluorobenzoic acid 2,5-dioxopyrrolidin-1-yl ester

cystamine dihydrochioride
56-17-7

cystamine dihydrochioride

N-(2-aminoethyldisulfide-2'-ethyl)-3-azido-4-fluorobenzamide
934611-73-1

N-(2-aminoethyldisulfide-2'-ethyl)-3-azido-4-fluorobenzamide

Conditions
ConditionsYield
With triethylamine In methanol at 0℃; for 0.666667h;97%
N-(4-fluoro-3-nitrophenyl)acetamide
351-32-6

N-(4-fluoro-3-nitrophenyl)acetamide

cystamine dihydrochioride
56-17-7

cystamine dihydrochioride

di-2-[(4-acetylamino-2-nitrophenyl)arnino]ethyl disuifide

di-2-[(4-acetylamino-2-nitrophenyl)arnino]ethyl disuifide

Conditions
ConditionsYield
With sodium hydrogencarbonate In dimethyl sulfoxide at 45 - 80℃; for 7h;97%
With sodium hydrogencarbonate In dimethyl sulfoxide at 45 - 80℃; for 7h;97%
di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

cystamine dihydrochioride
56-17-7

cystamine dihydrochioride

di-tert-butyl(disulfanediylbis(ethane-2,1-diyl))dicarbamate
67385-10-8

di-tert-butyl(disulfanediylbis(ethane-2,1-diyl))dicarbamate

Conditions
ConditionsYield
With triethylamine In 1,4-dioxane; water for 3h; Ambient temperature;96%
With triethylamine In 1,4-dioxane; water96%
With triethylamine In dichloromethane at 20℃; for 15h;96%
cystamine dihydrochioride
56-17-7

cystamine dihydrochioride

mitomycin J
74985-82-3

mitomycin J

7-N,7'-N'-bis(2-thioethyl)dimitomycin E

7-N,7'-N'-bis(2-thioethyl)dimitomycin E

Conditions
ConditionsYield
With triethylamine In methanol for 10h; Ambient temperature;96%
5-(dimethylamino)naphth-1-ylsulfonyl chloride
605-65-2

5-(dimethylamino)naphth-1-ylsulfonyl chloride

cystamine dihydrochioride
56-17-7

cystamine dihydrochioride

N,N’-(disulfanediylbis(ethane-2,1-diyl))bis(5-(dimethylamino)naphthalene-1-sulfonamide)
881013-37-2

N,N’-(disulfanediylbis(ethane-2,1-diyl))bis(5-(dimethylamino)naphthalene-1-sulfonamide)

Conditions
ConditionsYield
Stage #1: cystamine dihydrochioride With dmap; triethylamine In dichloromethane for 0.5h; Inert atmosphere;
Stage #2: 5-(dimethylamino)naphth-1-ylsulfonyl chloride In dichloromethane for 16h; Inert atmosphere;
96%
With sodium hydroxide; sodium hydrogencarbonate In water; acetone at 20℃; for 2h; pH=7.5;84%
With dmap; triethylamine In dichloromethane at 20℃;80%
N-(9H-fluoren-2-ylmethoxycarbonyloxy)succinimide
82911-69-1

N-(9H-fluoren-2-ylmethoxycarbonyloxy)succinimide

cystamine dihydrochioride
56-17-7

cystamine dihydrochioride

Fmoc-cystamine
896465-25-1

Fmoc-cystamine

Conditions
ConditionsYield
With sodium carbonate In water; acetone at 20℃; for 2.5h;96%
nickel(II) chloride hexahydrate

nickel(II) chloride hexahydrate

cystamine dihydrochioride
56-17-7

cystamine dihydrochioride

bis(cystamine)nickel(II) chloride

bis(cystamine)nickel(II) chloride

Conditions
ConditionsYield
With KOH In ethanol byproducts: KCl; addn. of KOH (0.01 mol) soln. (deaerated) to suspn. of cystamine, stirring, ice cooling, filtration, addn. of filtrate (dropwise, under N2 atm.) to NiCl2 (5 mmol) soln. (stirring), filtration; washing (EtOH, Et2O); elem.anal.;95%
2-pyrrole aldehyde
1003-29-8

2-pyrrole aldehyde

cystamine dihydrochioride
56-17-7

cystamine dihydrochioride

bis(2-(pyrrol-2-ylmethylenamino)ethyl)disulfide
132029-04-0

bis(2-(pyrrol-2-ylmethylenamino)ethyl)disulfide

Conditions
ConditionsYield
Stage #1: cystamine dihydrochioride With sodium hydrogencarbonate In ethanol; water at 20℃; for 1h;
Stage #2: 2-pyrrole aldehyde In ethanol; water
95%
cystamine dihydrochioride
56-17-7

cystamine dihydrochioride

Stearoyl chloride
112-76-5

Stearoyl chloride

{2-[(2-aminoethyl)disulfanyl]ethyl}octadecanamide
1256376-02-9

{2-[(2-aminoethyl)disulfanyl]ethyl}octadecanamide

Conditions
ConditionsYield
Stage #1: cystamine dihydrochioride With pyridine In N,N-dimethyl-formamide at 20℃; for 0.166667h;
Stage #2: Stearoyl chloride In N,N-dimethyl-formamide at 5 - 20℃; for 11h;
95%
cystamine dihydrochioride
56-17-7

cystamine dihydrochioride

benzoyl chloride
98-88-4

benzoyl chloride

N,N'-(2,2'-disulfanediylbis(ethane-2,1-diyl))dibenzamide
5205-42-5

N,N'-(2,2'-disulfanediylbis(ethane-2,1-diyl))dibenzamide

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 20℃; for 20h; Inert atmosphere;95%
With triethylamine In dichloromethane at 0 - 20℃;721 mg
cystamine dihydrochioride
56-17-7

cystamine dihydrochioride

9-anthracene aldehyde
642-31-9

9-anthracene aldehyde

C34H28N2S2
1539267-22-5

C34H28N2S2

Conditions
ConditionsYield
With triethylamine In ethanol for 1h; Reflux;95%
L-(-)-(tert-butyloxycarbonyl)-2,2-bimethylthiazolidine-4-carboxylic acid
19907-83-6

L-(-)-(tert-butyloxycarbonyl)-2,2-bimethylthiazolidine-4-carboxylic acid

cystamine dihydrochioride
56-17-7

cystamine dihydrochioride

L-(-)-(tert-butyloxycarbonyl)-2,2-bimethylthiazolidine-4-carboxylic acid

L-(-)-(tert-butyloxycarbonyl)-2,2-bimethylthiazolidine-4-carboxylic acid

Conditions
ConditionsYield
With sodium carbonate In tetrahydrofuran; water94.4%
cystamine dihydrochioride
56-17-7

cystamine dihydrochioride

p-toluenesulfonyl chloride
98-59-9

p-toluenesulfonyl chloride

N,N'-<(ethanodithio)ethano>bis-
23516-74-7

N,N'-<(ethanodithio)ethano>bis-

Conditions
ConditionsYield
With sodium hydroxide In dichloromethane; water at 20℃; for 12h;94%
With sodium hydroxide In diethyl ether; water 1.) 1 h, 0 deg C; 2.) 2 h, r.t.;90%
With sodium hydroxide In dichloromethane; water at 20℃; for 12h;90%
dabsyl chloride
56512-49-3

dabsyl chloride

cystamine dihydrochioride
56-17-7

cystamine dihydrochioride

(E)-4-((4-(dimethylamino)phenyl)diazenyl)-N-(2-mercaptoethyl)benzenesulfonamide

(E)-4-((4-(dimethylamino)phenyl)diazenyl)-N-(2-mercaptoethyl)benzenesulfonamide

Conditions
ConditionsYield
Stage #1: dabsyl chloride; cystamine dihydrochioride With triethylamine In acetonitrile at 0℃; for 2h;
Stage #2: With diothiothreitol In acetonitrile for 2h;
94%
cystamine dihydrochioride
56-17-7

cystamine dihydrochioride

1,2-bis(2-azidoethyl)disulfane
352305-38-5

1,2-bis(2-azidoethyl)disulfane

Conditions
ConditionsYield
With imidazole-1-sulfonyl azide hydrochloride; copper(ll) sulfate pentahydrate; potassium carbonate In methanol at 20℃; for 12h;94%
cystamine dihydrochioride
56-17-7

cystamine dihydrochioride

mitomycin B
4055-40-7

mitomycin B

7-N,7'-N'-bis(2-thioethyl)dimitomycin D

7-N,7'-N'-bis(2-thioethyl)dimitomycin D

Conditions
ConditionsYield
With triethylamine In methanol for 10h; Ambient temperature;93%
cystamine dihydrochioride
56-17-7

cystamine dihydrochioride

Ethyl oxalyl chloride
4755-77-5

Ethyl oxalyl chloride

N,N'-bis(ethoxyoxalyl)cystamine
1256735-90-6

N,N'-bis(ethoxyoxalyl)cystamine

Conditions
ConditionsYield
With potassium carbonate In dichloromethane at 0℃; for 1h; Schotten-Baumann reaction;93%

56-17-7Relevant articles and documents

Synthesis of reversible cyclic peptides

Ortiz-Acevedo, Alfonso,Dieckmann, Gregg R.

, p. 6795 - 6798 (2004)

Reversible cyclic peptides were synthesized by introducing a disulfide bond into the backbone of a peptide containing alternating d/l amino acids. The peptides exist in two distinct conformations (linear/cyclic) that are controlled by reduction/oxidation of the disulfide bond. A novel approach for the synthesis of cyclic peptides that can exist in either linear or cyclized conformations is described. Synthesis of the peptides was achieved via a modified solid phase methodology. The reversible linear/cyclized (i.e., open/closed) states are controlled via the reduction/oxidation of a disulfide bond incorporated into the backbone of the peptide chain.

Stereoselective synthesis of 4-substituted azetidine-2,3-diones by ring opening of 1,3-thiazolidine-derived spiro-β-lactams

Cremonesi, Giuseppe,Croce, Piero Dalla,Fontana, Francesco,Rosa, Concetta La

, p. 554 - 561 (2008/09/20)

New 3-heterocycle substituted 1,3-thiazolidine-derived 4-spiro-β-lactams with a relative trans-configuration were stereoselectively synthesised by means of a Staudinger ketene-imine reaction between the ketene generated from the (2S,4R)-1,3-thiazolidine-2,3,4-tricarboxylic acid 3-(1,1-dimethylethyl) 4-methyl ester 1 and imines 2b-e. The 1,3-thiazolidine-derived 4-spiro-β-lactams were transformed into the corresponding enantiomerically pure 4-heterocycle substituted azetidine-2,3-diones by means of an oxidative cleavage of the 1,3-thiazolidine ring. The opening of the 1,3-thiazolidine ring was studied under different experimental conditions and a consistent mechanism is proposed.

Organosulfur compounds as pre-exposure therapy for threat agents.

Ternay Jr.,Brzezinska,Sorokin,Cook,Lyaschenko

, p. S31-34 (2007/10/03)

A series of symmetric (Ar-S-S-Ar) and unsymmetric (Ar-S-S-CH2CH2NH3+Cl-) disulfides have been prepared and evaluated as potential cyanoprotective agents. Target compounds have been prepared by known methods and/or methods developed by us specifically for this program, e.g. reaction of a thiol with 2,2'-dithiobis(benzothiazole) (BT-S-S-BT) followed by reaction with a second thiol. Both 4-methoxyphenyl disulfide and 2-aminoethyl-4-methoxyphenyl disulfide hydrochloride are cyanoprotective against 2-LD50 of injected cyanide. Evaluation of both symmetric and unsymmetric related disulfides indicates that structural requirements for cyanoprotective activity are stringent and strongly suggest that protection is enzyme mediated. In addition to cyanoprotective action, initial results suggest that unsymmetric disulfides may evolve into effective antimustard agents.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 56-17-7